文献速递炎症性肠病

WISP1通过代谢与Rho/ROCK/MRTF介导的细胞骨架重塑驱动克罗恩病肠纤维化

WISP1 Drives Intestinal Fibrosis in Crohn's Disease via Metabolic and Rho/ROCK/MRTF-Mediated Cytoskeletal Remodeling.
PubMed 文献 · Gastroenterology · 2026-08-18

本研究探讨WISP1在克罗恩病肠纤维化中的作用。通过分析患者回肠组织的转录组、空间转录组和脂质组,并结合原代人肠成纤维细胞体外实验及小鼠纤维化模型,发现WISP1高表达于纤维化回肠,可促使成纤维细胞代谢从脂肪酸氧化转向糖酵解、诱导脂质蓄积和ECM沉积,并涉及RHO/ROCK/MRTFA通路;中和WISP1可减轻小鼠纤维化和炎症。

要点

  • WISP1在克罗恩病纤维化回肠中高表达,与WNT相关成纤维细胞亚群富集相关。
  • WISP1促使成纤维细胞代谢从脂肪酸氧化转向糖酵解,诱导脂质蓄积和ECM沉积。
  • 中和WISP1可减轻小鼠纤维化模型的胶原沉积、ECM复杂性、炎症和MRTF靶基因表达。

核心结论

  • WISP1连接WNT信号、细胞骨架重塑和代谢,驱动克罗恩病成纤维细胞介导的肠纤维化。
  • 中和WISP1可改善纤维化和炎症特征,提示其作为抗纤维化靶点的潜力。

研究设计与样本

  • 分析克罗恩病患者配对的纤维化、炎症和非纤维化回肠组织,采用bulk RNA测序、空间转录组学和脂质组学。
  • 使用原代人肠成纤维细胞进行体外实验,包括脂肪酸氧化、ECM分析、代谢流分析和蛋白质组/分泌组分析,并测试WISP1中和抗体在小鼠纤维化模型中的作用。

主要发现

  • WISP1在纤维化回肠中高表达,空间转录组显示WISP1+和WNT相关成纤维细胞亚群在纤维化区域富集,呈现促纤维化/糖酵解特征。
  • 组织学上ECM沉积和脂质蓄积是克罗恩病纤维化的关键特征。
  • WISP1处理体外使成纤维细胞代谢从脂肪酸氧化转向糖酵解,促进活性氧产生、脂肪因子分泌和脂质蓄积。
  • 抑制脂肪酸氧化促进ECM沉积,而PPARα激活恢复脂肪酸氧化并减少胶原产生。
  • WISP1驱动的纤维化涉及RHO/ROCK/MRTFA通路,纤维化组织中MRTFA/SRF特征增加。

临床怎么用

  • WISP1及其下游RHO/ROCK/MRTFA通路可作为克罗恩病肠纤维化的潜在治疗靶点。
  • 靶向成纤维细胞代谢重编程(如恢复脂肪酸氧化或激活PPARα)可能减少胶原产生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Intestinal fibrosis remains a debilitating complication of Crohn's disease (CD). Canonical WNT signaling and WISP1 are linked to tissue remodeling, but their role in intestinal fibrosis remains unclear. This study aims to elucidate how WISP1 regulates fibroblast activation, metabolic reprogramming, and extracellular matrix (ECM) remodeling as a novel target for stricturing CD. METHODS: Matched fibrotic, inflamed, and nonfibrotic ileal tissue from patients with CD was analyzed using bulk RNA sequencing, spatial transcriptomics, and lipidomics. Primary human intestinal fibroblasts were used for in vitro assays including fatty acid oxidation (FAO), ECM analysis, metabolic flux profiling, and proteome/secretome analysis with or without WISP1 stimulation. A WISP1-neutralizing antibody was tested in a murine fibrosis model. RESULTS: WISP1 was highly expressed in fibrotic ileum. Spatial transcriptomics revealed fibroblast heterogeneity, with WISP1+ and WNT-associated subsets enriched in fibrotic regions and displaying pro-fibrotic/glycolytic signatures. Histologically, ECM deposition and lipid accumulation were key features in CD fibrosis. WISP1 treatment in vitro shifted fibroblast metabolism from FAO to glycolysis, Reactive oxygen species production, promoted adipokine secretion, and induced lipid accumulation. Inhibition of FAO promoted ECM deposition, while PPARα activation restored FAO and reduced collagen production, linking metabolism to fibrogenesis. WISP1-driven fibrosis involved the RHO/ROCK/MRTFA pathway, supported by increased MRTFA/SRF signatures in fibrotic tissue. In vivo, WISP1 neutralization reduced collagen deposition, ECM complexity, inflammation, and MRTF target gene expression. CONCLUSIONS: WISP1 links WNT signaling, cytoskeletal remodeling, and metabolism to drive fibroblast-mediated fibrosis in CD. Its neutralization ameliorates fibrotic and inflammatory features, positioning WISP1 as a promising antifibrotic target.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Buck A, Writz C, Umbach M, et al. WISP1 Drives Intestinal Fibrosis in Crohn's Disease via Metabolic and Rho/ROCK/MRTF-Mediated Cytoskeletal Remodeling. Gastroenterology. 2026. PMID: 42612881. doi:10.1053/j.gastro.2026.07.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。